1. NCI website
2. Ferlay J et al, editors. Globocan 2000: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No.5. Version 1.0. IARC Press, 2001. Lyon, France.
3. Barrasso R, Guillemotonia A. Cervix and vagina: Diagnosis. In: Gross, Barrasso Eds. Human papillomavirus infection: A clinical atlas. Ullstein Mosby, 1997. p147–274.
4. Walboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
5. Munoz N. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 2000;19:1-5.
6. Pagliusi SR and Aguado MT. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine 2004;23:569-578.
7. Wieland U, Pfister H. Papillomaviruses in human pathology: Epidemiology, pathogenesis and oncogenic role. In: Gross, Barrasso Eds. Human papilloma virus infection: A clinical atlas. Ullstein Mosby; 1997. p1–18.
8. Centres for Disease Control and Prevention. Genital HPV infection fact sheet. Available at: http://www.cdc.gov/std/hpv/stdfact-hpv.html. Accessed July 22, 2005.
9. IARC Handbooks of Cancer Prevention. IARC Press; 2005. Chapter 4: Efficacy of screening. p163-199.
10. National Cancer Registry Ireland, Women and Cancer in Ireland, 1994-2001.
11. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
12. Koutsky LA, Galloway DA and Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10:122-163
13. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005;32(Suppl 1): S59-66.
14. Bosch FX, de Sajose S. Chapter 1: Human Paillomavirus and Cervical Cancer - Burden and Assesment of Casuality. Journal of the National Cancer Institute Monographs 2003; 31:3
15. Jacobs MV, Walboomers JMM, Snijders PJF et al. Distribution of 37 mucosotrophic HPV types in women with cytologicaclly normal cervical smears: The age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87:221-227.
16. Schiffman M and Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003;31:14–19.
17. Sherman ME, Lorincz AT, Scott DR et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis. J Natl Cancer Inst 2003;95:46–52
18. Health Protection Agency CDR Weekly. 2001;11(35).
19. NHS Cancer Screening Program. Cervical Screening - A Pocket Guide. Cervical Screening Pocket Guide 2005;1: 258
20. Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 2005;32S:S1-6.
21. Munoz N, Bosch FX, Castellsague X et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:278-285
22. Clifford GM, Smith JS, Plummer M et al. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 2003;88:63-73.
23. Clifford GM, Smith JS, Aguado T et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 2003;89:101-105.
24. Clifford GM, Rana RK, Franceschi S et al. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1157-1164.
25. Madeleine MM, Daling JR, Carter JJ et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997;89:1516-1523.
26. Daling JR, Madeleine MM, Schwartz SM et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002;84:263-270.
27. von Krogh G. Management of anogenital warts (condylomata acuminata). Eur J Dermatol 2001;11:598-604.
28. Winer RL, Lee S-K, Hughes JP et al. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218-226.
29. Sonnex C, Strauss S and Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Inf 1999;75:317-319.
30. Herrero R, Castellsague X, Pawlita M et al. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicentre study. J Natl Cancer Inst 2003;95:1772-1783.
31. Collins S, Mazloomzadeh S, Winter H et al. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. BJOG 2002;109:96-98.
32. Irish Cervical screening programme website accessed 28/09/2006
33. Irish Cancer Society, Irish Cancer Society News, www.ics.ie "Smear tests vital in preventing cervical cancer", accessed September 2006
34. Sawaya GF, McConnell KJ, Kulsingam SL et al. Risk of cervical cancer associated with extending the interval between cervical cancer screenings. N Engl J Med 2003;349:1501-1509.
35. Beutner KR and Wiley DJ. Recurrent external genital warts: A literature review. Papillomavirus Rep 1997;8:69-74.
36. Clinical Effectiveness Group (Association for Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National guideline for the management of anogenital warts.
37. Esiashvili N, Landry J and Matthews RH. Carcinoma of the anus: Strategies in management. The Oncologist 2002;7:188-199.
38. Kosko JR and Derkay CS. Role of cesarean section in prevention of recurrent respiratory papillomatosis – Is there one? Int J Pediatr Otorhinolaryngol 1996;35:31-38.
39. Silverberg MJ, Thorsen P, Lindeberg H et al. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg 2004;130:711-716.
40. McMillan A. The management of difficult anogenital warts. Sex Transm Inf 1999;75:192–194.
41. HSE, Sexually Transmitted Infections 2004, Annual Summary Report November 2005.
42. Quinn M, Babb P, Jones J et al. Effect of screening on incidence and mortality from cancer and cervix in England: Evaluation based on routinely collected statistics. BMJ 1999; 318: 904-908
43. Ferlay J et al, editors. Globocan 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No.5. Version 2.0. IARC Press, 2004. Lyon, France.
44. Maw RD, Reitano M and Roy M. An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998;9:571-578.
45. Kjaer SK, Chackerian B, van den Brule AJC et al. High-risk human papillomavirus is sexually transmitted: Evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001;10:101-106.
46. Winer RL et al. Condom use and the risk oh genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-54.
47. Cancerbackup Last access 14^th November 2006
48. Cancerbackup Last access 14^th November 2006

09548 02/07